Metastases of head and neck cancers to the axillary lymph nodes are rare. Our review of the literature found only fi ve such reports involving 10 patients. We describe a new case that occurred in a 69-year-old man who presented with a 6-week history of right neck swelling. Positron-emission tomography/computed tomography demonstrated high F18-fl uorodeoxyglucose uptake in the neck and also in the right axilla. Fine-needle aspiration cytology revealed squamous cell carcinoma (SCC) at both sites. The patient underwent right-sided radical neck dissection with pectoralis major myocutaneous fl ap reconstruction and axillary node block dissection. The patient was subsequently treated with chemoradiotherapy, but 6 months later he developed an SCC in the lung. The lung lesion was also treated with chemotherapy, but the patient died 5 months later. Our case is unique among similar cases in that our patient had not undergone any previous treatment of the neck primary. We discuss the mechanism of this unusual presentation. * Present case.
Introduction
Squamous cell carcinoma (SCC) accounts for 95% of all head and neck cancers. 1 Distant metastasis occurs in approximately 8% of these cases. 1 Based on our review of the English-language literature, metastases of head and neck cancers to the axilla are rare, as we found only fi ve such reports involving 10 patients. [1] [2] [3] [4] [5] However, Hoye et al 6 reported autopsy evidence of axillary metastasis in 2 to 9% of patients with head and neck cancer, and Kowalski 7 suggested that this fi gure may actually be higher because axillary nodes are not routinely dissected at autopsy unless they are clinically palpable.
In this article, we describe a new case of head and neck cancer metastatic to the axilla, and we discuss how this case was unique.
Case report
A 69-year-old man presented to the ENT Clinic with a 6-week history of right-sided neck swelling. He reported smoking at least 20 cigarettes per day and moderate alcohol consumption. He had no signifi cant medical history. On examination, a hard, nonmobile, 7-cm mass was felt underlying the right sternocleidomastoid muscle and extending into the posterior triangle. The tumor was fi xed to the overlying skin.
Fine-needle aspiration cytology identifi ed the mass as a moderately differentiated SCC. Based on this fi nding, panendoscopy was performed, and it revealed the presence of a suspicious lesion in the right piriform fossa. Biopsy analysis of this lesion revealed malignant squames. F18-fl uorodeoxyglucose (FDG) positronemission tomography/computed tomography (PET/ CT) demonstrated increased FDG uptake in both the right neck mass (standardized uptake value [SUV]: 9.6) and in a 1.5-cm right axillary lymph node (SUV: 6). Fine-needle aspiration cytology of the node confi rmed the presence of SCC. The patient was diagnosed with a category T2N3M1 SCC arising from the right piriform fossa.
The patient was taken to the operating room for a right radical neck dissection and right axillary clearance. During the neck dissection, we excised a paddle of skin from the anterolateral neck that had been infi ltrated by tumor. The patient required reconstruction with a pectoralis major myocutaneous fl ap.
Histologic examination revealed SCC and extracapsular invasion in six neck nodes and three axillary nodes. Examination of the skin also confi rmed malignant infi ltration.
The patient's initial postoperative recovery was unremarkable, and he subsequently underwent chemoradiotherapy. However, 6 months later he developed a SCC at the origin of the left main bronchus. Histologic examination was unable to determine whether the new lesion was a metastasis or a new primary. The patient remained under the care of the oncology service, where he underwent a course of chemotherapy. The patient died of widespread metastatic disease 5 months after the discovery of the lung metastasis.
Discussion
The case that we have presented here is unique among reported cases of head and neck cancer metastatic to the axilla in that our patient had not undergone any previous treatment of the head and neck primary. All 10 patients in the previously reported cases had undergone radical neck dissection, and all but 1 received radiotherapy (table). The metastasis in our patient was discovered at the same time as the primary.
Distant metastases arising from cancers of the head and neck usually follow a predictable pattern based on tumor histology and the site of origin. However, disturbance of the regional lymphatic system may alter the normal patterns of lymph fl ow. The axilla normally drains the lymphatics from the upper limb and chest wall toward the subclavian venous system along the axillary vein. Dissemination of disease into the axilla from the head and neck suggests an abnormal retrograde fl ow.
Alavi et al hypothesized that following surgery or radiotherapy, collateral channels develop that may alter lymph fl ow and make it bidirectional or unpredictable. 3 Retrograde lymph fl ow into the axilla from the supraclavicular, transverse cervical, and spinal accessory channels has previously been demonstrated. 8 Likewise, lymphography studies have shown that the axilla can become the major lymph drainage site from the anterolateral neck following radical neck dissection and radiotherapy. 2, 5 However, because our patient had not undergone any treatment of his neck primary, a different mechanism of dissemination must have occurred. Koch suggested that the tumor itself may alter the normal pattern of lymph drainage and lead to an abnormal dissemination of disease. 2 The unique nature of our case lends support to Koch's theory. Alternately, disease spread to the axilla might have occurred as a result of tumor invasion of the skin, since the axilla drains the skin from the upper chest wall. Another possibility is vascular dissemination to the axilla, but we believe this was less likely in our case. Finally, there is also the possibility that it was another primary tumor that metastasized to the axilla, and our patient did subsequently develop a lung lesion. But two factors count against the lung being the origin of the metastasis: (1) there was no evidence of lung involvement on the fi rst PET/CT scan and (2) lung tumors rarely metastasize to the axilla.
The authors of the fi ve previous case reports 1-5 have recommended axillary examination in high-risk head and neck cancer patients, and we support this recommendation. Although the role of PET/CT in the management of head and neck cancer patients is still to be resolved, our case highlights its ability to identify distant metastases, particularly when they disseminate to unusual sites.
The optimal management for patients who have developed an axillary metastasis is unknown, as there are too few cases to provide guidance. Still, axillary dissection appears to be the favored treatment. The prognosis for patients with a distant metastasis is poor. Calhoun et al 9 reported a mean survival of only 4.3 months, and most patients who have developed an axillary metastasis have died within 2 years. On the other hand, Nelson and Sisk reported that their patient survived 25 years following axillary dissection. 1 
